JP2026041958A5 - - Google Patents
Info
- Publication number
- JP2026041958A5 JP2026041958A5 JP2025244095A JP2025244095A JP2026041958A5 JP 2026041958 A5 JP2026041958 A5 JP 2026041958A5 JP 2025244095 A JP2025244095 A JP 2025244095A JP 2025244095 A JP2025244095 A JP 2025244095A JP 2026041958 A5 JP2026041958 A5 JP 2026041958A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- therapeutic agent
- lyso
- asmd
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832302P | 2013-06-07 | 2013-06-07 | |
| US61/832,302 | 2013-06-07 | ||
| JP2018236856A JP6835806B2 (ja) | 2013-06-07 | 2018-12-19 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2021015390A JP7414750B2 (ja) | 2013-06-07 | 2021-02-03 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2023220385A JP7830414B2 (ja) | 2013-06-07 | 2023-12-27 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220385A Division JP7830414B2 (ja) | 2013-06-07 | 2023-12-27 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026041958A JP2026041958A (ja) | 2026-03-10 |
| JP2026041958A5 true JP2026041958A5 (https=) | 2026-03-18 |
Family
ID=51062988
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016518053A Active JP6457501B2 (ja) | 2013-06-07 | 2014-06-06 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2018236856A Active JP6835806B2 (ja) | 2013-06-07 | 2018-12-19 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2021015390A Active JP7414750B2 (ja) | 2013-06-07 | 2021-02-03 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2023220385A Active JP7830414B2 (ja) | 2013-06-07 | 2023-12-27 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2025244095A Pending JP2026041958A (ja) | 2013-06-07 | 2025-12-10 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016518053A Active JP6457501B2 (ja) | 2013-06-07 | 2014-06-06 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2018236856A Active JP6835806B2 (ja) | 2013-06-07 | 2018-12-19 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2021015390A Active JP7414750B2 (ja) | 2013-06-07 | 2021-02-03 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
| JP2023220385A Active JP7830414B2 (ja) | 2013-06-07 | 2023-12-27 | 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 |
Country Status (29)
| Country | Link |
|---|---|
| US (4) | US10022428B2 (https=) |
| EP (2) | EP3004896B1 (https=) |
| JP (5) | JP6457501B2 (https=) |
| KR (3) | KR102292298B1 (https=) |
| CN (2) | CN105474017A (https=) |
| AU (5) | AU2014274670B2 (https=) |
| CA (1) | CA2914751C (https=) |
| CL (1) | CL2015003563A1 (https=) |
| CR (1) | CR20150638A (https=) |
| DK (1) | DK3004896T3 (https=) |
| EA (1) | EA035342B1 (https=) |
| ES (1) | ES2762608T3 (https=) |
| HR (1) | HRP20192246T1 (https=) |
| HU (1) | HUE047863T2 (https=) |
| IL (3) | IL298675B2 (https=) |
| LT (1) | LT3004896T (https=) |
| MA (1) | MA38638B1 (https=) |
| MX (1) | MX370570B (https=) |
| MY (1) | MY185990A (https=) |
| NZ (1) | NZ754328A (https=) |
| PH (1) | PH12015502687A1 (https=) |
| PL (1) | PL3004896T3 (https=) |
| PT (1) | PT3004896T (https=) |
| RS (1) | RS59677B1 (https=) |
| SG (2) | SG11201509622WA (https=) |
| SI (1) | SI3004896T1 (https=) |
| UA (1) | UA120591C2 (https=) |
| WO (1) | WO2014197859A1 (https=) |
| ZA (1) | ZA201508630B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3998078T1 (sl) * | 2009-08-28 | 2026-02-27 | Genzyme Corporation | Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze |
| LT3004896T (lt) * | 2013-06-07 | 2020-01-10 | Genzyme Corporation | Rūgštinės sfingomielinazės sutrikimų žymuo ir jo panaudojimas |
| JP6984854B2 (ja) * | 2015-10-08 | 2021-12-22 | 国立大学法人千葉大学 | ニーマン・ピック病ｃ型を予防または治療するための医薬組成物 |
| KR20250025051A (ko) * | 2017-08-24 | 2025-02-20 | 사노피 | 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료 |
| AU2018345303B2 (en) | 2017-10-02 | 2025-09-18 | Denali Therapeutics Inc. | Fusion proteins comprising enzyme replacement therapy enzymes |
| EP3976218B1 (en) * | 2019-05-31 | 2025-02-19 | Genzyme Corporation | Two-dimensional lc-ms/ms systems |
| EP4562432A2 (en) * | 2022-07-28 | 2025-06-04 | Wylder Nation Foundation | Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4082781A (en) | 1976-06-04 | 1978-04-04 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of 2-alkanoylamino-4-nitrophenyl phosphorylcholine-hydroxide |
| US4039388A (en) | 1976-06-04 | 1977-08-02 | The United States Of America As Represented By The Government | Diagnostic test for Niemann-Pick disease |
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| WO2002018539A2 (en) | 2000-08-25 | 2002-03-07 | Lysometrix Corporation | Method for assaying the activity of lysosomal enzymes |
| US7001994B2 (en) | 2001-01-18 | 2006-02-21 | Genzyme Corporation | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins |
| US7615224B2 (en) | 2004-12-02 | 2009-11-10 | Women's And Children's Hospital | Multiplex-bead complex for determination of lysosomal storage disorders |
| JP2006214731A (ja) | 2005-02-01 | 2006-08-17 | Institute Of Physical & Chemical Research | スフィンゴミエリンの検出方法 |
| JP2009519713A (ja) | 2005-12-15 | 2009-05-21 | ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク | 血漿中及び組織中のスフィンゴエミリン及びホスファチジルコリンの酵素的測定方法 |
| AR059089A1 (es) * | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| US8026099B2 (en) | 2007-07-26 | 2011-09-27 | Washington University | Lipid profile as a biomarker for early detection of neurological disorders |
| US8497122B2 (en) | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
| SI3998078T1 (sl) * | 2009-08-28 | 2026-02-27 | Genzyme Corporation | Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze |
| JP2013002933A (ja) | 2011-06-16 | 2013-01-07 | Hitachi Plant Technologies Ltd | ３次元測位システム |
| CA2854668A1 (en) | 2011-11-15 | 2013-05-23 | Centogene Ag | Method for the diagnosis of niemann-pick disease |
| ES2731920T3 (es) * | 2013-05-14 | 2019-11-19 | Centogene Ag | Método para el diagnóstico de la enfermedad de Niemann-Pick |
| LT3004896T (lt) * | 2013-06-07 | 2020-01-10 | Genzyme Corporation | Rūgštinės sfingomielinazės sutrikimų žymuo ir jo panaudojimas |
-
2014
- 2014-06-06 LT LTEP14735056.5T patent/LT3004896T/lt unknown
- 2014-06-06 WO PCT/US2014/041405 patent/WO2014197859A1/en not_active Ceased
- 2014-06-06 PL PL14735056T patent/PL3004896T3/pl unknown
- 2014-06-06 IL IL298675A patent/IL298675B2/en unknown
- 2014-06-06 NZ NZ754328A patent/NZ754328A/en unknown
- 2014-06-06 HR HRP20192246TT patent/HRP20192246T1/hr unknown
- 2014-06-06 JP JP2016518053A patent/JP6457501B2/ja active Active
- 2014-06-06 CA CA2914751A patent/CA2914751C/en active Active
- 2014-06-06 CN CN201480043918.2A patent/CN105474017A/zh active Pending
- 2014-06-06 US US14/895,472 patent/US10022428B2/en active Active
- 2014-06-06 ES ES14735056T patent/ES2762608T3/es active Active
- 2014-06-06 EP EP14735056.5A patent/EP3004896B1/en active Active
- 2014-06-06 SG SG11201509622WA patent/SG11201509622WA/en unknown
- 2014-06-06 KR KR1020217007269A patent/KR102292298B1/ko active Active
- 2014-06-06 MA MA38638A patent/MA38638B1/fr unknown
- 2014-06-06 HU HUE14735056A patent/HUE047863T2/hu unknown
- 2014-06-06 EA EA201592265A patent/EA035342B1/ru not_active IP Right Cessation
- 2014-06-06 IL IL284102A patent/IL284102B2/en unknown
- 2014-06-06 RS RS20191627A patent/RS59677B1/sr unknown
- 2014-06-06 KR KR1020167000011A patent/KR102228367B1/ko active Active
- 2014-06-06 KR KR1020217025969A patent/KR102434244B1/ko active Active
- 2014-06-06 MY MYPI2015704368A patent/MY185990A/en unknown
- 2014-06-06 DK DK14735056.5T patent/DK3004896T3/da active
- 2014-06-06 SG SG10201709925SA patent/SG10201709925SA/en unknown
- 2014-06-06 EP EP19191053.8A patent/EP3584580A1/en active Pending
- 2014-06-06 AU AU2014274670A patent/AU2014274670B2/en active Active
- 2014-06-06 PT PT147350565T patent/PT3004896T/pt unknown
- 2014-06-06 UA UAA201600158A patent/UA120591C2/uk unknown
- 2014-06-06 MX MX2015016844A patent/MX370570B/es active IP Right Grant
- 2014-06-06 SI SI201431434T patent/SI3004896T1/sl unknown
- 2014-06-06 CN CN202210555370.6A patent/CN115128287A/zh active Pending
-
2015
- 2015-11-23 ZA ZA2015/08630A patent/ZA201508630B/en unknown
- 2015-12-01 PH PH12015502687A patent/PH12015502687A1/en unknown
- 2015-12-04 CR CR20150638A patent/CR20150638A/es unknown
- 2015-12-04 CL CL2015003563A patent/CL2015003563A1/es unknown
- 2015-12-06 IL IL242964A patent/IL242964B/en unknown
-
2018
- 2018-02-09 AU AU2018200977A patent/AU2018200977B2/en active Active
- 2018-06-08 US US16/003,598 patent/US10888607B2/en active Active
- 2018-12-19 JP JP2018236856A patent/JP6835806B2/ja active Active
-
2020
- 2020-10-22 AU AU2020257114A patent/AU2020257114B2/en active Active
- 2020-12-11 US US17/119,035 patent/US11998592B2/en active Active
-
2021
- 2021-02-03 JP JP2021015390A patent/JP7414750B2/ja active Active
-
2023
- 2023-02-23 AU AU2023201062A patent/AU2023201062B2/en active Active
- 2023-12-27 JP JP2023220385A patent/JP7830414B2/ja active Active
-
2024
- 2024-04-29 US US18/649,453 patent/US12589138B2/en active Active
-
2025
- 2025-08-25 AU AU2025220876A patent/AU2025220876A1/en active Pending
- 2025-12-10 JP JP2025244095A patent/JP2026041958A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026041958A5 (https=) | ||
| McLaughlin et al. | Dolutegravir-induced hyperglycaemia in a patient living with HIV | |
| KR102766876B1 (ko) | 타우로데옥시콜린산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 코로나바이러스감염증-19(covid-19) 치료용 조성물 | |
| KR20170128633A (ko) | 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도 | |
| JP2016526050A5 (https=) | ||
| El Messaoudi et al. | Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study | |
| CN115397431A (zh) | 用于治疗涉及全身过度炎症反应的病症的eclitasertib | |
| Yokoyama et al. | Low-dose sirolimus for a patient with blue rubber bleb nevus syndrome | |
| JP2019513123A (ja) | 凍結医薬製剤およびその使用 | |
| US20250127787A1 (en) | Methods for treating peripheral neuropathy | |
| JP7490654B2 (ja) | 持続的腎代替療法における経皮的糸球体濾過量測定の使用 | |
| CN1090491A (zh) | 预防及治疗脓毒症的方法 | |
| RU2286770C2 (ru) | Антигриппозное средство | |
| CN116171151A (zh) | 用于治疗病毒感染的pde3抑制剂 | |
| JP3987599B2 (ja) | 筋ジストロフィー治療剤 | |
| RU2739212C1 (ru) | Препарат для комплексной терапии заболеваний, вызванных бета-коронавирусами | |
| Zhang et al. | Recovery of a 91-year-old COVID-19 Patient with Medical and Psychological Support | |
| RU2227034C2 (ru) | Способ лечения саркоидоза | |
| Maleki et al. | The COVID-19 Infection Complicated with Chylopericardium in a Six-Month-Old Boy After Glenn Shunt Surgery; A Rare Phenomenon in the Pediatric | |
| Massarella et al. | Effect of congestive heart failure on the pharmacokinetics of cibenzoline | |
| Zar et al. | Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children | |
| Wang et al. | Effects of Food on the Pharmacokinetics and Bioequivalence of Oseltamivir Phosphate for Suspension and TAMIFLU® in Healthy Chinese Subjects: A randomized, open-label Clinical Trial. | |
| Thomaidis et al. | Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complications | |
| Revishvili et al. | Dynamics of pulmonary injury and extracorporeal methods of hemocorrection in patients with Sars-CoV-2 | |
| Gao et al. | Study on the Nursing Efficacy of Clopidogrel Combined With Oxiracetam in the Treatment of Patients with Cerebral Infarction. |